Cargando…
Improved chemotherapy modeling with RAG-based immune deficient mice
We have previously characterized an acute myeloid leukemia (AML) chemotherapy model for SCID-based immune deficient mice (NSG and NSGS), consisting of 5 days of cytarabine (AraC) and 3 days of anthracycline (doxorubicin), to simulate the standard 7+3 chemotherapy regimen many AML patients receive. W...
Autores principales: | Wunderlich, Mark, Manning, Nicole, Sexton, Christina, Sabulski, Anthony, Byerly, Luke, O’Brien, Eric, Perentesis, John P., Mizukawa, Benjamin, Mulloy, James C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6867639/ https://www.ncbi.nlm.nih.gov/pubmed/31747424 http://dx.doi.org/10.1371/journal.pone.0225532 |
Ejemplares similares
-
PD-1 Inhibition Enhances Blinatumomab Response in a UCB/PDX Model of Relapsed Pediatric B-Cell Acute Lymphoblastic Leukemia
por: Wunderlich, Mark, et al.
Publicado: (2021) -
Rag1 Deficiency Impairs Arteriogenesis in Mice
por: Kumaraswami, Konda, et al.
Publicado: (2023) -
Recent advances in understanding RAG deficiencies
por: Gennery, Andrew
Publicado: (2019) -
Clinical, Immunological, and Molecular Variability of RAG Deficiency: A Retrospective Analysis of 22 RAG Patients
por: Cifaldi, Cristina, et al.
Publicado: (2021) -
Improved multilineage human hematopoietic reconstitution and function in NSGS mice
por: Wunderlich, Mark, et al.
Publicado: (2018)